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ABSTRACT
Obesity is an inflammatory disease associated with the development and progression of
chronic degenerative diseases including insulin resistance, cardiovascular disease (CVD), type 2
diabetes mellitus (T2DM), and cancer. Circulating free fatty acid (FFA) are known risk factors
promoting inflammation that can lead to CVD. Pre/adipocytes are known storage of low grade
inflammatory biomarkers associated with obesity. However, the effects of dietary anthocyanins
on inflammatory biomarkers in preadipocytes have not been reported. Berries are rich sources of
naturally occurring antioxidant polyphenolics. There is increasing interest in the ability of berry
anthocyanins to provide health benefits against obesity. Anthocyanins were isolated from
blueberry, blackberry, cranberry and black currant and analyzed by spectrophotometry and liquid
chromatography. The objective of this study was to test the effect of berry anthocyanins on
palmitic acid (PA)-induced inflammatory biomarkers in human preadipocytes. Comparison was
made with the effect of berry anthocyanins on lipopolysaccharide (LPS)-induced inflammation
in similar human preadipocytes. Preadipocytes from obese women were incubated with different
concentrations (10-40μM) of berry anthocyanins for 24 h followed by addition of 100 μM PA
and additional incubation for 24h or 100ng/ml of LPS for 8 h. In another treatment,
preadipocytes were incubated with 100 μM PA for 24h or 100ng/ml of LPS for 8 h and then
incubated with 10-40μM anthocyanins for 24h. All incubations were performed at 37 °C in a 5%
CO 2 humidified incubator. Pro-inflammatory cytokines IL-6, IL-8 and MCP-1 were analyzed in
conditioned preadipocyte media by ELISA. NF-κB and COX-2 from preadipocyte lysates were
analyzed by Western Blot. PA or LPS induced up-regulation of the pro-inflammatory biomarkers.
Berry anthocyanins significantly inhibited PA- or LPS-induced inflammation when anthocyanins
were added to the preadipocytes prior to PA or LPS addition. However, the same anthocyanins
were weak inhibitors of PA- or LPS-induced inflammation when preadipocytes were first
ix

incubated with LPS or PA. The results of our investigation show that berry anthocyanins may be
effective in preventing PA- or LPS-induced low-grade inflammation in preadipocytes.
Keywords: berry anthocyanins; human preadipocytes; inflammation; palmitic acid;
lipopolysaccharide; cytokines
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CHAPTER 1
INTRODUCTION
Obesity is a condition that contributes to human morbidity and mortality. It is associated
with increased risk of chronic diseases including cardiovascular disease, type 2 diabetes mellitus
(T2DM), high blood pressure, high cholesterol, and certain types of cancers (Ginsberg, 2000;
James, 2008; Karlsen et al., 2007). Obesity-related diseases have significant economic impact on
the United States health care system and the health systems in many other countries. A vast body
of research exists demonstrating that obesity is a complex disorder with a strong genetic basis
and a multifactorial etiology (Bray, 2008). The fundamental cause of obesity is an energy
imbalance between calorie consumption and calorie expenditure. High-caloric intake and
sedentary life style are two risk factors in the modern society that contribute to obesity.
Low grade or chronic inflammation is closely associated with the development and
continuation of obesity. The development of inflammation is characterized by the excess
production of cytokines and the activation of inflammatory signal pathways (Tsukumo et al.,
2007). Obesity is frequently associated with chronic cytokines production in adipose tissue,
including tumor necrosis factor-α (TNF-α), interleukin-β (IL-1β), interleukin 6 (IL-6),
interleukin 8 (IL-8), and monocyte chemotactic protein 1 (MCP-1) (Hotamisligil et al., 1993).
Preadipocytes play important roles in the overall regulation of glycemia in T2DM. Preadipocytes
cause persistently high levels of circulating free fatty acid, reduced peripheral glucose utilization,
increased hepatic glucose production and decreased insulin sensitivity (Bays et al., 2004).
Growing evidence has also demonstrated that pro-inflammatory cytokines such as TNF-α and
MCP-1 impair adipocyte insulin sensitivity (Hotamisligil et al., 1994; Sartipy et al., 2003).
Edible berries such as blackberry, blueberry, cranberry and black currant are relatively
low-calorie fruits. The bioactive compounds in these berries have many benefits to human
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health. The bioactive phytochemicals from edible berries have been demonstrated to provide
antioxidant, anti-inflammatory, cytoprotective and neurological benefits (Julie Beattie, 2005).
Anthocyanins are critical phytochemicals in berries and possess anti-oxidant, anti-inflammation,
anti-obesity, anti-diabetes, and anti-cancer properties (Lee et al., 2009; Wang et al., 2002a).
However, few studies have investigated the anti-inflammatory effects of berry anthocyanins in
human preadipocytes. Therefore, the main objective of the present study was to investigate the
potential inhibitory effects of berry anthocyanins on PA- or LPS- induced (secretion)
inflammatory biomarkers in human preadipocytes. Steps taken to achieve the objective were:
1. To isolate anthocyanins from blackberry, blueberry, cranberry or black currant
2. To determine the concentrations and profiles of anthocyanins in the berry extracts
3. To investigate the prevention effects of the berry anthocyanins on pro-inflammatory
cytokines secretion in human preadipocytes
4. To study the intervention effects of berry anthocyanins on pro-inflammatory
cytokines secretion by human preadipocytes
5. To establish possible links between anthocyanins and inflammation
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CHAPTER 2
LITERATURE REVIEW
2.1 Definition of Obesity
Obesity is presently one of the greatest public health challenges around the world.
Overweight and obese conditions generally are the result of abnormal or excessive fat
accumulation in the body. Body mass index (BMI) is a simple index of weight-for-height that is
commonly used to classify underweight, overweight and obesity in adults. It is defined as the
weight in kilograms divided by the square of his or her height in meters (kg/m2). A person with a
BMI below 18.5 is underweight. The normal range of BMI is between 18.50 and 24.99. A person
with a BMI equal to or more than 25 is considered overweight. A person with a BMI of 30 or
more is regarded as obese.
2.2 Risk Factors of Obesity
A vast body of research exists demonstrating that obesity is a complex disorder with a
strong genetic basis and a multifactorial etiology (Bray, 2008). Basically, the fundamental cause
of overweight or obese condition is the energy imbalance between calorie consumption and
calorie expenditure. Over the last 50 years, there has been a trend of increased intake of
calorically dense foods that are high in fat, sugars and salt but low in vitamins, minerals and
other micronutrients. There has been a simultaneous trend of decreasing physical activity due to
the increasingly sedentary nature of many forms of work, changing modes of transportation, and
increasing urbanization (French et al., 2001; Kumanyika, 2001). The combination of excessive
food energy intake and lack of physical activity is the main cause of obesity.
Leptin is a protein hormone and plays an important role in the regulation of energy intake
and expenditure. Leptin is almost exclusively expressed within adipocytes and serves as a signal
of stored adipose to the brain. It has been reported that leptin influences food intake through a
3

direct effect on the hypothalamus (Halaas et al., 1995; Lee et al., 1996; Zhang et al., 1994).
Leptin levels correlate with the amount of stored body fat in both humans and animals. The
infusion of leptin decreases feeding and increases metabolic rate in rodents (Considine et al.,
1996; Frederich et al., 1995; Halaas et al., 1995; Maffei et al., 1995; Pelleymounter et al., 1995).
In addition to the complex pathways, fat cell size also correlates with obesity (Avram et
al., 2007) and with the degree of macrophage infiltration into the adipose tissue (Weisberg et al.,
2003). The development of obesity is dependent on the coordinated interplay of adipocyte
hypertrophy (increased fat cell size), adipocyte hyperplasia (increased fat cell number), and
angiogenesis (Avram et al., 2007). The enlarged adipocytes of obese individuals recruit
macrophages and promote inflammation and the release of a range of factors that predispose
toward insulin resistance (Greenberg et al., 2006). Insulin is a hormone that regulates the
metabolism of carbohydrate and fat in the body. Insulin resistance (IR) is a condition in which
normal concentration of insulin fail to maintain normal blood glucose because of decreased
responsiveness of peripheral tissues, including muscles (glucose uptake), liver (inhibition of
gluconeogenesis) and fat cells (inhibition of lipolysis) (Zhuang et al., 2009).
Adiponectin, an adipocyte complement-related protein, enhances insulin sensitivity in
muscle and liver and increases FFA oxidation in several tissues (Greenberg et al., 2006).
Adiponectin also decreases serum FFA, glucose, and triacylglycerol concentrations (Fruebis et
al., 2001). In terms of the risk factors associated with obesity, the methodologies controlling
energy balance and adipocyte formation may achieve the purpose of prevention and intervention
of obesity.
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2.3 The Relation between Free Fatty Acid and Obesity
The average American diet is abundant in saturated fatty acids (SFA), such as palmitate
and stearate. Foods high in SFA include fast foods, processed foods, high-fat dairy products, red
meats, and pork (USDA, 2008). The mean daily per capita consumption of fat in the U.S. in
2003–2004 was 82.7 g, which exceeds the recommended amount by 16.0 g, based on a 8400 kJ
diet (Kennedy et al., 2009). Overconsumption of fatty acid contributes to weight gain and
inflammation (Lundman et al., 2007). The circulation of FFAs, especially saturated FFAs,
increase obesity and diabetes (Lu et al., 2003). SFAs are also believed to contribute substantially
to coronary artery disease (Jakobsen et al., 2009).
Palmitic acid (PA, C16:0) is one of the most common saturated fatty acid found in
animals and plants. It also broadly exists in the daily diet including butter, cheese, milk and meat.
The WHO claims that dietary intake of PA increases the risk of developing cardiovascular
diseases (Geneva, 2003). In addition, PA is the major saturated fatty acid in serum FFA (2332%) and adipose tissue TG (19.5-27%). Unbound PA at plasma physiological concentrations
from 100 to 500 μM induces the production of inflammatory biomarkers including IL-6, IL-8,
MCP-1, and cyclooxygenase-2 (COX-2) (Ajuwon et al., 2005; Samokhvalov et al., 2009).
2.4 Obesity and Inflammation
2.4.1 Inflammation
Inflammation is a complex series of reactions executed by the host to prevent ongoing
tissue damage, to activate repair processes and to provide defense mechanisms against infectious
diseases (Karlsen et al., 2007). Prolonged inflammation can contribute to the pathogenesis of
chronic diseases such as diabetes, neurodegenerative type 2 diabetes, cancers, hypertension,
atherosclerosis, and cardiovascular disease. Dampening of inflammation may potentially retard
5

the development of such of diseases (Hoareau et al., 2009; Karlsen et al., 2007). The
development and continuation of obesity is closely associated with a state of chronic, low-grade
inflammation characterized by abnormal cytokine production and activation of inflammatory
signaling pathways (Tsukumo et al., 2007). Obesity also exacerbates inflammation because
visceral and subcutaneous fat store inflammatory cytokines including tumor necrosis factor-α
(TNF-α), interleukin-β (IL-1β), interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1),
inducible nitric oxide synthase, transforming growth factor β1, and procoagulant proteins (Fried
et al., 1998; Grimble, 2002; Hotamisligil et al., 1993; Perreault et al., 2001; Samad et al., 1997;
Sartipy et al., 2003; Weyer et al., 2002; Zhu et al., 2008).
2.4.2 Biomarkers of Inflammation
The primary risk factors for chronic inflammation include Interleukin-1β (IL-1β),
Interleukin-6 (IL-6), Interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1),
cyclooxygenase-2 (COX-2), transcription nuclear factor-κB (NF-κB), and tumor necrosis factorα (TNF-α). In adipose tissue metabolism, cytokines are major regulators, particularly the IL-1
system. There are four main members of the IL-1 cytokine family: IL-1α, IL-1β, IL-1 receptor
antagonist (IL-1ra) and IL-18. In general, the IL-1 family is considered to be pro-inflammatory
and pro-atherogenic except IL-1ra which is regarded as an anti-inflammatory cytokine (Girn et
al., 2007). IL-1β is a major cytokine placed high in hierarchical (auto) inflammatory cascades. It
is potentially involved in the pathogenesis of atherosclerosis and other cardiovascular diseases
(Manica-Cattani et al., 2010). Elevated circulating levels of IL-1β have been reported in obesity
(Garanty-Bogacka et al., 2005). In vitro studies in human adipose tissue have suggested that
endogenous release of IL-1β and TNF-α up-regulate IL-6 production (Fain et al., 2005).
Blocking IL-1β results in a rapid and sustained reduction in the severity of most auto6

inflammatory diseases (Dinarello, 2011). IL-6 is a multifunctional inflammatory cytokine. It
stimulates immune responses and is secreted from a wide variety of cell types (Ershler et al.,
2000). Circulating levels of IL-6 are significantly higher in obese humans and animals. IL-6
increases FFA and fat oxidation in humans and plasma IL-6 concentrations are correlated with
insulin resistance (Kern et al., 2001; van Hall et al., 2003). IL-6 acts synergistically with other
regulatory factors to affect the development of several chronic diseases such as cardiovascular
disease and Type 2 diabetes (Pradhan et al., 2001; Yudkin et al., 2000). Another preinflammatory marker TNF-α produced in adipose tissue is also associated with obesity and
insulin resistance in patients with or without Type 2 diabetes (Hotamisligil et al., 1994; Kern et
al., 2001). It was reported that TNF-α stimulates the IL-8 production in human adipocytes
(Gerhardt et al., 2001). IL-8, a chemokine, is known to activate neutrophils, which is enhanced
by inflammatory substances such as TNF-α, IL-1β, and C-reactive protein (CRP). NF-κB is a
sequence specific transcription factor implicated in the transmission of different signals from
cytoplasm to the nucleus, which plays an important role in regulating inflammatory and immune
genes, apoptosis, and cell proliferation (de Winther et al., 2005). NF-κB is also a pivotal factor in
controlling the inflammatory and metabolic alterations associated with obesity (Sonnenberg et
al., 2004; Wellen et al., 2005). NF-κB mediates induction of pro-inflammatory cytokines,
including IL-1, IL-6, and TNF-α.
2.5 Human Subcutaneous Adipocytes
Adipose tissue comprises 20% of the body weight of healthy individuals making it one of
the largest organs in the body (Cinti, 2007).The main function of adipose tissue is an energy
reservoir. Adipose tissue accumulates triacylglycerol when excess calories are intake (Tsuda,
2008). Adipose tissue also acts as an endocrine organ. It secretes a large number of proteins
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known as adipokines. The adipokines impact a variety of biological functions, including energy
balance, glucose homeostasis, lipid metabolism and inflammation (Greenberg et al., 2006; Meier
et al., 2004; Siiteri, 1987; Trujillo et al., 2006; Zhang et al., 1994). Adipose tissue contains
multiple cell types, including endothelial cells, macrophages, adipocytes and preadipocytes (Xu
et al., 2003). Adipocytes, once considered solely as energy depot cells, are actually recognized as
active endocrine cells that secrete cytokines, polypeptides and hormone-like molecules. In fact,
their progenitors, preadipocytes, also secrete a large number of cytokines, polypeptides and
hormone-like molecules (Kershaw et al., 2004; Trayhurn et al., 2001; Xu et al., 2003).
Adipocytes are major drug targets due to their central role in a vast array of
pathophysiological processes that include obesity, diabetes, inflammation and cancer (Nawrocki
et al., 2005). The expression levels of adipose-derived cytokines are postulated to be risk factors
for cardiovascular disease, diabetes, hypertension, and other components of the metabolic
syndrome (Trayhurn, 2005). Adipocytes are very strongly implicated in the inflammatory
process associated with the development of obesity (Hoareau et al., 2009). Preadipocytes are
present throughout adult life in adipose tissue and can proliferate and differentiate into mature
adipocytes. Preadipocytes have the potential to “transdifferentiate” into macrophages (Charriere
et al., 2003). Preadipocytes are adipogenic progenitor cells which possess a characteristic
pathway of multipotent adult stem cells and are able to differentiate in vitro into adipogenic,
osteogenic, chondrogenic, myogenic and neurogenic lineages under specific culture conditions
(Scanarotti et al., 2010).
2.6 Dietary Approach to Reduce Obesity
2.6.1 Anthocyanins in Berries
Bioactive compounds in foods have attracted much attention because of their potential
8

benefits to human health. Micronutrients in plants, animals or marine foods play an important
role in maintaining human health. Edible berries have been a part of human’s diet for centuries.
As with other fruit and vegetables, berries are important dietary sources of fiber and essential
vitamins and minerals. Berries also contain several phytochemicals, such as phenolic acids,
proanthocyanidins, anthocyanins and other flavonoids. In vitro studies suggest that berry extracts
can modulate cancer development processes by inhibiting the growth and proliferation of cancer
cells, including cell death, and impairing angiogenesis through inhibition of expression of
vascular endothelial growth factor VEGF (Roy et al., 2002). It has also been reported that
blackberry, cherry, raspberry, blueberry, and bilberry extracts can inhibit LDL oxidation which is
a key factor for the development of coronary arteries (Heinonen, 2007; Laplaud et al., 1997).
Anthocyanins are the largest group of water-soluble pigments responsible for the blue,
purple and red color of many plant tissues in the plant kingdom (Prior et al., 2006).
Anthocyanins are conjugated anthocyanidins, which provide the distinctive and vibrant palate of
colors in berries. Anthocyanins are abundantly present in chokeberry, cherry, aubergine, blue
grape, vaccinium, red cabbage, and the Usambara-violet (Tsoyi et al., 2008). They are widely
distributed in the human diet through the consumption of crops, beans, fruits, vegetables, and red
wine. Hollman and Katan (1999) and Scalbert and Williamson (2000) have found the average
daily intake of anthocyanins by humans to range from 25 to 1000 mg.
Anthocyanins possess anti-oxidant, anti-inflammation, anti-obesity, anti-diabetes, and
anti-cancer properties (Lee et al., 2009; Wang et al., 2002a). They also play a role in the
reduction of coronary heart disease (Bridle and Timberlake, 1996). Anthocyanins can also
increase visual acuity (Timerlake and Henry, 1988).
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Much attention has focused on the ability of compounds such as anthocyanins and
flavonols to act as antioxidants. The antioxidant effectiveness of anthocyanins and other
polyphenols in vitro is essentially due to the ease with which a hydrogen atom from an aromatic
hydroxyl group is donated to a free radical (Rice-Evans et al., 1997). In addition, anthocyanins
can chelate transition metal ions involved in radical-forming processes such as Fenton reactions
(Ferrali et al., 1997; Morel et al., 1993). They can also induce endogenous antioxidants (Fiander
et al., 2000).

Anthocyanins
Pelargonidin
Cyanidin
Delphinidin
Peonidin
Petunidin
Malvidin

R1
H
OH
OH
OCH 3
OCH 3
OCH 3

R2
H
H
OH
H
OH
OCH 3

Color
orang-red
red
pink
bluish purple
purple
redish purple

Fig.2.1 Structures of major anthocyanin
Blackberries (Rubus L. hybrids), blueberries (Vaccinium L. species), cranberry
(Vaccinium Macrocarpum), and black currants (Ribes nigrum L.) are rich sources of dietary
anthocyanins and antioxidants (Hong Wang, 1996; Kahkonen et al., 1999). The anthocyanins in
the berries form conjugates with sugars including glucose, sophorose, rutinose, rhamnose,
galactose, arabinose and xylose (Fig.2.1). Six anthocyanins most commonly found in plants are
classified according to the number and position of hydroxyl groups on the flavan nucleus. They
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are named cyanidin (cy), delphinidin (dp), malvidin (mv), peonidin (pn), pelargonidin (pg), or
petunidin (pt) (Valls et al., 2009) as shown in Fig.2.2.
Cyanidin-3-glucoside is the major anthocyanin found in blackberry (Garcıia-Viguera et
al., 1997; Goiffon et al., 1991). The major anthocyanins in blueberries are malvidin-3-galactose
and malvidin-3-glucose, but other minor anthocyanins are also present (Seeram et al., 2006).
Cranberries possess a distinctive flavor and a bright red color. The predominant anthocyanins in
American cranberries are 3-O-galactosides and 3-O-arabinosides of cyanidin and peonidin
(Mazza, 1993; Prior et al., 2001). Black currant skin is known to contain four major
anthocyanins, namely cyanidin-3-O-glucoside, cyanidin-3-O-rutinoside, delphinidin-3-Oglucoside and delphinidin-3-O-rutinoside (Kapasakalidis et al., 2006).
2.6.2 Anthocyanins and Inflammation
Numerous studies have proven the anti-inflammation effect of anthocyanins.
Anthocyanin was reported to have inhibited the secretion of pro-inflammatory cytokines such as
IL-8, MCP-1, IL-1β, cytokine-induced neutrophil chemoattractant-1, IL-6, and TNF-α in cellular
and animal models (Guo et al., 2008; Tsuda, 2008; Zhang et al., 2010). Similarly, Karlsen et al.
(2007) observed that anthocyanins reduced the secretion of several molecules related to
inflammatory modulation, specifically vascular endothelial growth factor and intracellular
adhesion molecule-1 in cellular models (Karlsen et al., 2007).
Anthocyanin-rich berry extracts showed considerable inhibitory effects on nitric oxide
(NO) production in LPS/interferon-γ (IFN-γ) activated RAW264.7 macrophages (Wang et al.,
2002b). Anthocyanin-rich blackberry extracts have potent antioxidant, anti-proliferative, and
anti-inflammatory activities. Anthocyanin-rich berry extracts showed considerable inhibitory
effects on nitric oxide (NO) production in LPS/interferon-γ (IFN-γ) activated RAW264.7

11

Cyanidin

Delphinidin

Malvidin

Peonidin
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Petunidin
Fig.2.2 Chemical structures of anthocyanins
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macrophages (Wang et al., 2002b). Anthocyanin-rich blackberry extracts have potent
antioxidant, anti-proliferative, and anti-inflammatory activities. Blackberry extract-formulated
products have the potential for the treatment and/or prevention of cancer and/or other
inflammatory disease (Dai et al., 2007). Blueberries contain a wide range of bioactive
compounds including anthocyanin, flavonols, flavanols, and stilbenes (de Pascual-Teresa et al.,
2000). A study has shown that blueberry extract inhibited the production of the inflammatory
mediator NO, the cytokines IL-1β and TNF-α in BV2 cells activated to inflammation by LPS
(Lau et al., 2007). Cranberries are an excellent source of anthocyanin, flavonol glycosides,
proanthocyanidins and phenolic acids (Kandil et al., 2002; Prior et al., 2001). Polyphenolic
extracts from cranberry inhibited the growth and proliferation of breast, colon, prostate, lung,
and other tumors (Neto, 2007). Anthocyanin and hydroxycinnamic acids from blueberry and
cranberry protected endothelial cells against TNF-α induced inflammatory responses (Youdim et
al., 2002). Constituents present in black currant juice have been found to exert a number of
health-promoting effects, including immune modulatory, antimicrobial and anti-inflammatory
actions, inhibition of low-density lipoprotein, and reduction of cardiovascular diseases (Bishayee
et al., 2010).
2.6.3 Anthocyanins and Preadipocytes
DeFuria et al. (2009) showed that the salutary effects of berries on adipocyte physiology
may reflect the ability of anthocyanin to alter mitogen-activated protein kinase and nuclear
factor-kappaB stress signaling pathways, which regulate cell fate and inflammatory genes
(DeFuria et al., 2009). Cyanidin 3-glucoside has a significant potency of anti-obesity and
ameliorates adipocyte function in the in vitro and in vivo systems. It has important implications
for preventing metabolic syndrome (Tsuda, 2008). When preadipocytes were induced in the

13

presence of anthocyanins (1-40 µg/ml), the accumulation of cytoplasmic triglycerides was
reduced in a dose- and time- dependent manner in 3T3-L1 preadipocytes (Bong-Gi Lee, 2007).
Alaskan berries increased the expression levels of preadipocyte factor 1 and reduced lipid
accumulation in 3T3-L1 adipocytes (Kellogg et al., 2010). However, little evidence has shown
that anthocyanins-rich extracts from blackberry, blueberry, cranberry and black currant have
anti-inflammatory effects induced by PA or LPS in human preadipocytes.
In summary, obesity is a health problem in the U.S and around the world. Currently
pharmaceutical strategies are mainly used to lose weight; however, these are not suitable for
every obese person. Therefore, other strategies must be developed to solve the obesity problem.
From the cause of obesity, we know it is mainly because of the intake of too much high energy
food. Hence, we need to utilize a more ideal diet in our daily life and also to increase physical
activities to maintain an energy balance. In addition, obesity is closely associated with various
chronic diseases especially inflammation which is a chronic risk factor for metabolic syndrome.
This study focused on the interactions between inflammatory biomarkers in human
preadipocytes and anthocyanins isolated from blackberry, blueberry, cranberry, and black
currant.
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CHAPTER 3
MATERIALS AND METHODS
3.1 Reagents
HPLC grade acetonitrile and methanol were purchased from Fisher Chemicals (Fair
Lawn, N.J.). Trifluoroacetic acid (TFA) was purchased from Sigma-Aldrich (St. Louis, MO.).
DMEM/F-12 (1:1) liquid media, Fetal bovine serum, trypsin, phosphate buffered saline were
obtained from Fisher Scientific (Pittsburgh, PA). Lipopolysaccharide (Escherichia coli 0111:B4)
and palmitic acid were purchased from Sigma (St.Louis, MO). Bio-Rad DC protein assay kit was
purchased from Bio-Rad Laboratories (Hercules, CA). PVDF membranes and 4-12% Bis-Tris
gel were obtained from Invitrogen (Carlsbad, CA). Bovine serum albumin (BSA), primary
antibodies, NF-κB p65 and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). COX-2 primary antibody was purchased from Cayman Chemical (Ann Arber, Michigan).
Peroxidase-conjugated secondary antibodies were obtained from Jackson Immunoresearch (West
Grove, PA). X-ray film was purchased from Phoenix Research (Candler, NC).
3.2 Anthocyanin Extraction and Concentration Determination
Frozen blackberry (Marionberry, Rubus L. subgenus), blueberry (Duke, Vaccinium
corymbosum), cranberry (Ben Lear, Vaccinium macrocarpon), and black currant (Jet, Rubes
nigrum) fruits were supplied by Frito Lay, Inc (Dallas, TX). Frozen berry fruits were ground in a
commercial blender. The liquefied samples were lyophilized in a Genesis XL-35 lyophilizer
(VirTis Co., NY).
Twenty g of lyophilized berries were extracted with 100 ml acidified methanol containing
0.01% (v/v) HCl and gently shaken in laboratory shaker for 1 h at room temperature. The slurry
was filtered through a Whatman No.1 filter paper by vacuum suction using a Buchner funnel.
This extraction step was repeated for 5 times until all the pigment were extracted. The filtrates
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were combined and evaporated in a rotary evaporator at 40 ℃ under vacuum. The resulting paste
was stored at -20 °C until use.

The total anthocyanin concentration was determined by the pH-differential method
(Giusti & Wrolstad, 2000). All measurements were performed in triplicate. Two buffer systems
were used: 0.025 M potassium chloride buffer at pH 1.0 and 0.4 M sodium acetate buffer at pH
4.5. The berry extracts were diluted with pH 1.0 potassium chloride solution. The absorbance of
the solution was read at 700 nm using the following formula: A = (A 520 nm - A 700 nm ) pH1.0 –(A 520
nm

- A 700 nm ) pH4.5
Monomeric anthocyanin pigment concentration in the original sample using the following

formula: Monomeric anthocyanin pigment (mg/liter) =

𝐴𝐴 ×𝑀𝑀𝑀𝑀 ×𝐷𝐷𝐷𝐷 ×1000
𝜀𝜀 ×1

where MW is the

molecular weight and DF is the dilution factor. The 𝜀𝜀 value reported in the literature for

anthocyanin pigment (cyanindin-3-glucoside) in acidic aqueous solvent was 26,900 and the MW
is 449.2 (Giusti et al., 2001).
Anthocyanin pigments will combine with bisulfate to form a colorless sulfonic acid
adduct. Polymerized colored anthocyanin-tannin complexes are resistant to bleaching by
bisulfate, whereas the bleaching reaction of monomeric anthocyanins will rapidly go to
completion. The ratio between polymerized color and color density is used to determine the
percentage of the color that is contributed by polymerized material (Giusti et al., 2001). Color
density of the sample treated with water was determined using the relation: (A 420 nm - A 700 nm ) +

(A vis-max - A 700 nm )*DF. DF is the dilution factor. The polymeric color of sample treated with
bisulfite was calculated as: (A 420 nm - A 700 nm ) + (A vis- max - A 700 nm )*DF: The percent polymeric
color was determined as: (polymeric color/color density)* 100
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3.3 HPLC Analysis
3.3.1 Anthocyanins Profiles by HPLC Analysis
The HPLC system consisted of a Supelco (Bellefonte, Pa.) Discovery C18 column
(internal diameter 3 mm × 25 cm), a Waters 2690 separation module, a 996 photodiode array
detector, and a Millennium32 chromatography manager (Waters, Milford, Mass.). The mobile
phase was a mixture of (A) 0.4% TFA in water and (B) acetonitrile, with the percentage of (A)
0.4% TFA in water ramped from 100% to 55% in 45 min with a constant flow rate of 0.8
ml/min. The peaks of anthocyanidins were confirmed by matching their retention times and UV–
visible absorption spectrum with standards. The chromatograms obtained at a wavelength of 520
nm were used to quantify the anthocyanins and anthocyanidins. The concentrations were
calculated using their standard or corresponding anthocyanidin standard calibration curves.
3.3.2 Phenolics Profiles by HPLC Analysis
The phenolics profiles analysis used the same HPLC system and Discovery C18 column.
The chromatograms monitored at all wavelengths from 200 to 600 nm. Gradient elution was
performed with solution A, composed of 50 nM sodium phosphate (pH3.3) and 10% methanol,
and solution B, comprising 70% methanol, delivered at a flow rate of 1.0 mL/min as follows:
initially 100% of solution A; for the next 15 min, 70% A; for another 30 min, 65% A; for another
20 min, 60% A; for another 5 min, 50% A; and finally 0% A for 25 min. The injection volume
for the extract was 25 μl.
3.4 Cell Culture
Human subcutaneous preadipocytes from four donors (Table 3.1) were obtained from the
Stem Cell Biology Laboratory, Pennington Biomedical Research Center. Liposuction aspirates
were obtained from female subcutaneous adipose tissue sites (abdomen, flank, thighs)
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undergoing elective plastic surgical procedures. Tissues were washed with phosphate buffered
saline (PBS) three to four times and suspended in an equal volume of PBS with 1% bovine
serum albumin and 0.1% collagenase type I (Worthington Biochemical Corporation, Lakewood,
NJ) prewarmed to 37 ℃. The tissues were continuously agitated for 60 min at 37℃ and
centrifuged for 5 min at 300 × g at room temperature (Aust et al., 2004; Dubois SGHY-D, 2005;
Halvorsen et al., 2001; Sen et al., 2001). The supernatant containing mature adipocytes were
removed. The precipitated pellet was identified as the stromal vascular fraction (SVF). The SVF
was suspended and plated in T225 flasks in Stromal Media at a density of 0.156 ml of tissue
digest/cm2 of surface area for expansion and culture (DMEM/F-12 Ham’s. 10% fetal bovine
serum (Hyclone, Logan, UT), 100 U penicillin/100 µg streptomycin/0.25 µg Fungizone).
The initial passage of the primary cell culture was referred to as “passage 0” (P0) for the
adherent adipose-derived stem cell (ASC) population. Following the first 48 h of incubation at
37 ℃ and 5% CO 2 , the cultures were washed with PBS and maintained in Stromal Media until
75-90% confluence was achieved (approximately 6 days). The cells were passaged by trypsin
(0.05%) digestion and plated at a density of 5,000 cells/cm2 (“passage 1”). The cells were
maintained in DMEM/F-12 medium containing 10% BFS and100 U penicillin/100 µg at 37°C in
humidified atmosphere containing 5% CO 2 . The cells were seeded at a density of 5×104/cm2.
After 48 h, the cells were treated.
Table 3.1 Human preadipocytes donor demographics: age, gender and Body Mass Index
Donor
L070711
L080909
L090724
L090330
Mean ± S.D.

Gender
Female
Female
Female
Female

Age (Year)
41
47
47
45
45±2.8

18

Body Mass Index
28.22
31.61
26.65
26.46
28.2 ±2.4

3.5 Crystal Violet Cell Viability Assay
Human preadipocytes were treated with 100 µM or 250 µM palmitic acid (PA) or 100
ng/ml lipopolysaccharide (LPS), and incubated for 2, 4, 8, 24, or 48 h in a humidified incubator
containing 5% CO 2 at 37°C. Each treatment was carried out in triplicate. Cell viability was
determined by the crystal violet assay (Wosikowski et al., 1993). Cell viability was expressed as
the percentage of control cells.
3.6 Interaction between PA or LPS and Human Preadipocytes
Human preadipocytes were seeded in 12 well plates and incubated over night at 37℃ and
5% CO 2 in a humidified atmosphere. Blackberry (BAB), blueberry (BUB), cranberry (CRB) or
black currant (BC) extracts (0, 10, 20, and 40 µM) were added and incubated for 24 h; Palmitic
acid (PA) was then added to a final concentration of 100 µM. The cells were incubated for an
additional 24 h. The concentration of anthocyanin was determined in this procedure.
Two approaches were tested to emulate the intervention and prevention of inflammation.
In the prevention approach, berry anthocyanins were incubated with preadipocytes for 24 h
followed by 100 µM PA treatment for 24 h. Similarly, berry anthocyanins were incubated with
preadipocytes for 24 h followed by 100 ng/ml LPS for 8 h. In the intervention approach, human
preadipocytes were treated with 100 µM PA for 24h, followed by addition of berry anthocyanins
for 24 h. In the comparison group, LPS was used to induce inflammation. Human preadipocytes
were treated with 100 ng/ml LPS for 8 h, followed by addition of berry anthocyanins and 24 h
incubation.
3.7 Enzyme Linked Immunosorbent Assay for Pro-inflammatory Cytokines
ELISA for human IL-6, IL-8 and MCP-1 levels in the conditioned media for control and
treated cells were performed using commercially available kits from Peprotech (Rock Hill, NJ)
according to the manufacturer’s instructions. Human IL-6, IL-8 and MCP-1 ELISA development
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kit contains the key components required for the quantitative measurement in a sandwich ELISA
format. Recombinant standard human IL-6, IL-8 and MCP-1 served as the standard for
quantitative evaluation. All standards and samples were tested in triplicate.
Intervention

Prevention

Human preadipocytes culture

Human preadipocytes culture

Add 100 µM PA or 100 ng/ml LPS

Add berry anthocyanin
Incubate for 24 h

Incubate PA-treated for 24 h

Add 100 µM PA or 100 ng/ml LPS
Incubate PA-treated for 24 h

Add berry anthocyanin
Incubate for 24 h

Incubate LPS-treated for 8 h

Collect supernatant and
cell lysates
Supernatant
Cell lysates

Collect supernatant and
cell lysates
Supernatant
Cell lysates

ELISA

Incubate LPS-treated for 8 h

ELISA

Western blot

Western blot

Figure 3.1 Interactions of anthocyanins with PA or LPS
3.8 Western Blot
Control and treated cells were washed with ice cold PBS, lysed with ice cold RIPA
(Radio-Immunoprecipitation Assay) buffer (50 mM Tris-HCL, pH7.5, 1% Nonidet P-40, 0.1 mM
EDTA, 0.1 mM EGTA, 0.1% SDS, 0.1% deoxycholic acid), and centrifuged at 14,000 ×g for 10
min at 4 ℃. The supernatants were collected. Protein concentrations of the supernatants were
determined by Bio-Rad DC protein assay following manufacturer’s instructions (Bio-Rad
Laboratories, CA). Briefly, pipet 5 μl of standards and samples into 96 wells plates; add 25 μl of
reagent A into each well; add 200 μl reagent B into each well. After 15 minutes, absorbance can
be read at 655 nm. For Western blot analyses, 30 µg protein lysates per sample were denatured in

20

9 µl 4×NuPAGE LDS sample buffer. The volume of the sample was adjusted to 36 µl with water,
and then boiled at 100°C for 5 min. Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) was run with 4-12% Bis-Tris gel. The proteins separated were then transferred to
polyvinylidene fluoride (PVDF) membrane. Residual binding sites on the membrane were
blocked by incubation in TBST (10 mM Tris, 100 mM NaCl, 0.1% Tween20) with 3% (w/v)
bovine serum albumin (BSA) for 1 hour at room temperature. The membranes were probed with
specific primary antibodies at 4℃ overnight, followed by peroxidase-conjugated secondary
antibodies. After incubation with 1st and 2nd antibodies, the blots were washed five times with 10
ml tris buffered saline solution (TBST) for 5 min each time. The blots were visualized with
SuperSignal West Pico Chemiluminescent substrate (Fisher Scientific) and exposed to X-ray
film (Kodak X-omat 1000A processor).
3.9 Statistical Analyses
The results are expressed as means ± standard deviation. Each experiment was conducted
using (3-4) donors and each treatment was carried out independently in triplicates. For
comparison of the differences among the groups, ANOVA was used, followed by Tukey’s post
hoc test. Statistical significance was set at P-value < 0.05.
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CHAPTER 4
RESULTS AND DISCUSSION
4.1 Anthocyanins Concentration Determination
To determine the anthocyanins concentration in blackberry, blueberry, cranberry or black
currant, we performed the test by using the spectrophotometric method reported by Giusti &
Wrolastad (2001). The results are presented in Table 4.1. The results show that black currant
contained the highest level of anthocynins among the four fruits, whereas the cranberry used
contained the lowest levels. Marcin Horbowicz (2008) reported that the anthocyanins content in
blackberry were 83-326 mg/100g and blueberry had 25-495 mg anthocyanins per 100 g fruit
(Marcin Horbowicz, 2008). Our results show that anthocyanins concentration in blackberry was
98.1 ± 4.1 mg in 100 g fresh fruits and blueberry had 56.0 ± 5.9 mg anthocyanins per 100 g fresh
fruits (Table 4.1). Timberlake et al. (1988) reported that the total anthocyanin of black currant
ranges from 130 to 400 mg/100g fresh fruits (Timberlake, 1988). Our results show that the
anthocyanins in black currant are 136.5 ± 2.0 mg/100g. The total content of anthocyanins in
cranberry fruits range from 180 to 656 mg/Kg of fresh weight (Wang et al., 2001). Cranberry had
39.2 ± 5.7 mg/100g in fresh fruits. The results of anthocyanin concentration in this study are
consistent with previous reports. The concentrations of anthocyanins in berries vary according
genotype, growth environment, storage time, storage conditions, extraction methods and the
detection methods (Dai et al., 2009; Yue et al., 2008).
Polymeric anthocyanins were determined by spectrophotometer and the results are
presented in Table 4.1. Blueberry and black currant have 22.8% and 29.7% polymeric
anthocyanins, respectively. The values are relatively higher than blackberry or cranberry which
had a concentration of 5.98% and 5.15% polymeric anthocyanins, respectively. Processing may
result in increase in polymeric color values and losses of monomeric anthocyanins (Hager et al.,
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2008). Polymers have a higher affinity for cellular material than lower molecular weight
compounds due to the presence of multiple binding sites on large molecules (Le Bourvellec et
al., 2004; Renard et al., 2001).
Table 4.1 Monomeric anthocyanins and percentage of polymeric anthocyanins in berries
Monomeric Anthocyanin in
Polymeric Anthocyanin in
frozen fruits (mg/100g)
frozen fruits (%)
98.1 ± 4.1
Black berry (Marionberry)
6.0 ± 2.0
56.0 ± 5.9
Blueberry (Duke)
22.8 ± 3.7
39.2 ± 5.7
Cranberry (Ben Lear)
5.2 ± 3.2
136.5 ± 2.0
Black currant(Ben Tirran)
29.7 ± 0.5

4.2 Polyphenols Content by HPLC Analysis
4.2.1Anthocyanins Content in Berry Extracts
To determine the profile of anthocyanins in the four berries, we performed HPLC
analysis of the extracts. The results of blackberry are presented in Fig.4.1A. Three anthocyanins
were found in blackberry extracts (Table 4.2). The total anthocyanin content was 267.0 mg/100g
of the extract. The main anthocyain in blackberry extract was cyanidin glucoside which
represented 92.2% of the total anthocyanin content.
The anthocyanins profile in the blueberry extract by HPLC method is shown in Fig. 4.1B.
Ten different anthocyanins were found in blueberry extracts (Table 4.2). The main anthocyains
in blueberry extract included cyanidin 3-arabinoside, petunidin 3-glucoside, peonidin 3galactoside, and malvidin 3-galactoside which is cyanidin glucoside. For the blueberry extract,
malvidin 3-galactoside represented 11.5% of the total anthocyanins (107.4 mg/100g).
The anthocyanins profile in the cranberry extract by HPLC method is shown in Fig. 4.1C.
Six anthocyanins were found in the cranberry extract (Table 4.2). The main anthocyanins in
cranberry extract included cyanidin 3-galactoside, cyanidin 3-arabinoside, peonidin 3galactoside, and peonidin 3-arabinoside. The content of each of the anthocyanins was more than
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10% of the total compounds extracted. The total anthocyanin content was 57.5 mg/100g of the
extract.
The HPLC analysis of anthocyanins in the black currant extract is shown in Fig. 4.1D.
Seven anthocyanins were found in black currant extract (Table 4.2). The main anthocyanins in
black currant extract were delphinidin 3-glucoside, delphinidin 3-rutinoside, and cyanidin 3rutinoside. The content of each of the anthocyanins mentioned above was more than 10% in the
total anthocyanins. The total anthocyanins content was 137.9 mg/100g.
Briefly, both the pH differential and HPLC methods are commonly used methods to
quantify anthocyanins in berries. Comparison of the results from the two analytical methods
shows that overall values by HPLC method were higher than the pH differential method. This
trend is in agreement with a reported study (Lee et al., 2008).
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Fig.4.1. Anthocyanins profiles in the berry extracts by HPLC analysis. A: blackberry
extract; B: blueberry extracts; C: cranberry extract; D: black currant extract.
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Table 4.2 Anthocyanin profile and content in the berry extracts
Retention time
Content
Compounds
(min)
mg/100g
Black berry (Marionberry) extract
1
cyanidin 3-glucoside
12.2
246.2
2
cyanidin 3-rutinoside
13.1
16.1
3
cyanidin 3-dioxalyglucoside
19.7
4.7
Total
267.0 mg/100g
Blueberry (Duke) extract
1
delphinidin 3-galactoside
9.4
6.6
2
delphinidin 3-glucoside
10.2
3.8
3
cyanidin 3-galactoside
11.3
9.5
4
delphinidin 3-arabinoside
12.1
5.7
5
cyanidin 3-glucoside
13.2
6.2
6
petunidin 3-galactoside
14.3
6.6
7
cyanidin 3-arabinoside
14.9
24.3
8
petunidin 3-glucoside
15.9
11.8
9
peonidin 3-galactoside
16.9
20.4
10 malvidin 3-galactoside
19.7
12.3
Total
107.4 mg/100g
Cranberry (Ben Lear) extract
1
cyanidin 3-galactoside
11.3
19.9
2
cyanidin 3-glucoside
12.2
1.4
3
cyanidin 3-arabinoside
13.3
9
4
peonidin 3-galactoside
14.5
18.6
5
peonidin 3-glucoside
15.4
2.4
6
peonidin 3-arabinoside
16.2
6.2
Total
57.5 mg/100g
Black currant (Ben Tirran) extract
1
delphinidin 3-glucoside
10.6
34.1
2
delphinidin 3-rutinoside
11.1
73.9
3
cyanidin 3-glucoside
12.4
17
4
cyanidin 3-rutinoside
13.3
68.2
5
petunidin 3-rutinoside
14.2
2.8
6
peonidin 3-rutinoside
16.1
1.9
7
cyanidin 3-coumaroylglucoside
19.8
9.5
Total
137.9 mg/100g
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% of total
anthocyanin
92.2
6.0
1.8

6.2
3.5
8.9
5.3
5.8
6.2
22.7
11.0
19.0
11.5

34.6
2.4
15.7
32.3
4.2
10.8

16.4
35.6
8.2
32.9
1.4
0.9
4.6

4.2.2 Other Polyphenols Content in the Berry Extracts
Polyphenolics in vegetables, fruits, and tea are able to prevent degenerative diseases
through antioxidative action (Sakakibara et al., 2002). Other polyphenols content in the same
berry extracts from blackberry, blueberry, cranberry or black currant were also determined by
HPLC methodology described in Chapter 3.3.2. The results of other polyphenols are showed in
the Table 4.3. The mainly polyphenols in the berry extracts using acidified methanol are
anthocyanins. Other polyphenols are trace amount compared with anthocyanins. This
observation is consistent with previous studies (Fan-Chiang et al., 2005; Wrolstad, 2001).
Therefore, the anthocyanins in the berry extracts are the major functional polyphenols for the
potential benefits of human health.
Table 4.3 Other polyphenols content in the berry extracts
Wavelength for
Berry extract
Polyphenols
determination (nm)
0.325
0.007
0.023
Cranberry

Black currant

Content (mg/100g)

Cafechin

280

32.5

Chlorofeuic

320

0.7

Chlorofeuic

320

2.3

Caffeic acid

320

0.2

Cafechin

280

4.3

Chlorofeuic

320

3.6

Gallic acid

250

3.9

Protocateuic

280

0.1

Cafechin

280

13.4

Chlorofeuic

320

0.6

Caffeic acid

320

1.0
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4.3 Effects of PA or LPS on Cell Viability Assay
To determine the effects of PA or LPS on cell viability in preadipocytes, the crystal violet
assay was performed on human preadipocytes treated with 100 or 250 µM PA or100 ng/ml LPS.
The cell viability results are shown in Fig 4.2. There was no significant difference (P>0.05)
between 100 μM PA and control treatments. There was also no significant difference (P>0.05)
between 250 μM PA and control treatments. Similarly, the viability of 100 ng/ml LPS treated
cells shows no significantly difference (P>0.05) compared to control cells. The results suggest
that PA or LPS at the concentrations used had no cytotoxic effects on human preadipocytes at the
dosages uses.
140
120

Cell Viability %

100
80
60
40
20
0
2h

Control

4h

PA 100 μM

8h

PA 250μM

24h

48h

LPS 100ng/ml

Fig.4.2 Effects of palmitic acid (PA) or lipopolysaccharide (LPS) on cell viability. PA (100 μM
or 250 μM), and LPS (100 ng/ml) treated human preadipocytes for 0-48 hours. The values were
expressed as percentage of untreated control cells.
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4.4 Effects of PA or LPS on Pro-inflammatory Cytokine IL-6
To determine the effects of PA or LPS on IL-6, ELISA was performed to detect the IL-6
levels in the supernatants from the control and PA- or LPS- treated preadipocytes. The results for
the IL-6 analysis are presented in Fig.4.3. PA at 100 μM induced IL-6 secretion in a timedependent manner. The maximal mean levels of IL-6 reached 1542 pg/ml in conditioned media
after 24 h of PA exposure and it is significantly higher (P<0.05) than the IL-6 level in the
control. The levels of secreted IL-6 did not increase in a strict time dependent manner following
exposure to PA at 250 μM. IL-6 level exposed to 250 μM PA at 48 h is even lower than 24 h,
and the statistical analysis showed that the IL-6 level was not significantly different (P>0.05)
with the IL-6 level in the control. PA or LPS are potent agonists for activated inflammation and
express the multiple cytokines in adipocytes (Ajuwon et al., 2005; Corre et al., 2006; Kilroy et
al., 2007; Samokhvalov et al., 2009). Based on the preliminary results from this study and the
results reported in literature (Samokhvalov et al., 2009), I decided to expose human
preadipocytes for 24 h.
LPS at 100 ng/ml increased IL-6 secretion in conditioned human preadipocytes media in
a time-dependent manner (Fig.4.3). The IL-6 level secreted by Human preadipocytes was
significantly increased (P<0.05) after two hours incubation with 100 ng/ml LPS. Following the
exposure to LPS, the IL-6 accumulation reached to a maximal mean level of 5549 pg/ml in
conditioned media after 48 h (Fig. 4.3). The IL-6 level in the conditioned media incubated with
100 ng/ml LPS for 8 hours was five times of the control. LPS at the concentration of 100 ng/ml
was able to induce acute inflammation in human preadipocytes in 8 hours. Based on the result
obtained from this study and the result reported in the literature (Kilroy et al., 2007), I chose 8 h
exposure time in 100 ng/ml LPS.
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Fig.4.3 Effect of PA or LPS on IL-6 secretion. Human preadipocytes were treated by PA 100 μM
or 250 μM or LPS 100 ng/ml for 0-48 hours. The columns represent the mean ± S.D. of triplicate
determinations, *: P < 0.05.
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4.5 Effects of Anthocyanins on the Cell Viability of the Cells Treated with PA or LPS
To determine the prevention effects of anthocyanins on preadipocytes viability treated
with PA, crystal violet analysis was performed as the described in chapter 3.5. For prevention
method, the results in Fig.4.4 demonstrate that the anthocyanins did not significantly affect
(P>0.05) preadipocytes viability when cells were pretreated with anthocyanins extracts from
BAB, BUB, CRB, and BC (0- 40 μM) for 24 h, followed by the treatment of 100 μM PA for 24
h. The intervention effects of anthocyanins on preadipocytes viability are shown in Fig. 4.5.
There was also no significant difference (P>0.05) in viability of preadipocytes when they were
stimulated with 100 μM PA for 24 h, followed with anthocyanins from BAB, BUB, CRB, and
BC (0-40 μM) for 24 h. The results demonstrated that anthocyanins (0-40 μM) were not
cytotoxic to human preadipocytes. Previous studies have also shown that an anthocyanin,
cyanidin-3-glucoside, at 40 μM was not cytotoxic to adipocytes (Guo et al., 2008).
To determine the effects of anthocyanins on preadipocytes viability treated with LPS, the
crystal violet analysis was performed as the method in chapter 3.5. The viability results of the
prevention method are shown in Fig.4.6. The results of crystal violet assay demonstrates that
there was no significant difference (P>0.05) in preadipocytes viability when they were pretreated
with anthocyanins from BAB, BUB, CRB, and BC (0-40 μM) for 24 h, followed by 100 ng/ml
LPS for 8 h. The viability results of intervention are shown in Fig. 4.7. There was also no
significant difference (P>0.05) in viability of preadipocytes when they were stimulated with 100
ng/ml LPS for 8 h, followed with anthocyanins from BAB, BUB, CRB, and BC (0-40 μM) for
24 h. The results confirmed that at anthocyanins at concentration between 0 and 40 μM were not
cytotoxic to human preadipocytes.
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Fig. 4.4 Prevention effects of anthocyanins on viability of human preadipocytes stimulated by
PA. Human preadipocytes were pretreated with different concentrations of anthocyanins for 24 h,
followed by the treatment of 100 μM PA for 24 h. The human preadipocytes were from one
donor. Results are representatives of three independent experiments. The columns represent the
mean ± S.D. of triplicate determinations.
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Fig. 4.5 Intervention effects of anthocyanins on viability of human preadipocytes stimulated by
PA. Human preadipocytes were stimulated with 100 μM PA for 24 h, followed with the addition
of different concentrations of anthocyanins extracted from BAB, BUB, CRB, and BC. The
viability of the cells was determined for 24 h after the addition of the anthocyanins. The human
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The columns represent the mean ± S.D. of triplicate determinations.
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Fig. 4.6 Prevention effects of anthocyanins on the viability of human preadipocytes stimulated by
LPS. Human preadipocytes were pretreated with different concentrations of anthocyanins
extracted from BAB, BUB, CRB, and BC for 24 h, followed by the treatment of 100 ng/ml LPS
for 8 h. The human preadipocytes were from one donor. Results are representatives of three
independent experiments. The columns represent the mean ± S.D. of triplicate determinations.
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Fig. 4.7 Intervention effects of anthocyanins on the viability of human preadipocytes stimulated
by LPS. Human preadipocytes were stimulated with 100 ng/ml LPS for 8 h, followed with the
treatment of different concentrations of anthocyanins extracted from BAB, BUB, CRB, and BC
for 24 h. The human preadipocytes were from one donor. Results are representatives of three
independent experiments. The columns represent the mean ± S.D. of triplicate determinations.
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4.6 Effects of Anthocyanins on Pro-inflammatory Cytokine IL-6
To determine the preventative effects of anthocyanins on the levels of IL-6 in PA- treated
human preadipocytes, the cells were pretreated with 0, 10, 20, and 40 μM of the anthocyanins
extracted from the four different types of berries. The cells were then treated with 100 μM PA
for 24 h. IL-6 ELISA was performed on the supernatants of the control and treated
preadipocytes. The results of the IL-6 levels in the conditioned media are shown in Fig.4.8. The
anthocyanins extracted from four different berries reduced the IL-6 secretion induced by 100μM
PA in a dose-dependent manner and the effectiveness also varied with the types of berries.
Blackberry anthocyanins significantly (P<0.05) attenuated the IL-6 levels induced by PA at a
dosage of 40 μM. However, 10 and 20 µM blackberry anthocyanins did not significantly
decrease (P>0.05) the IL-6 level. For the anthocyanins extracted from blueberry, significant IL-6
reduction was observed at a dosage of 20 and 40 μM. For the anthocyanins extracted from
cranberry and black currant, all dosages, 10, 20 and 40 μM, significantly reduced the production
of IL-6. Previous studies by other researchers demonstrated that anthocyanins at a concentration
range from 0 to 40 µM can inhibited the production of inflammatory cytokines induced by H 2 O 2
in 3T3 adipocytes (Guo et al., 2008).
To investigate the effects of anthocyanins on IL-6 secretion induced by LPS, a similar
experiment was carried out. In the experiment, human preadipocytes were pretreated with 10, 20
and 40 μM of anthocyanins extracted from the different berries for 24 h. A control (no
anthocyanin addition) was also included. The cells were then treated with 100 ng/ml LPS for 8 h.
The IL-6 in the supernatant of the samples was tested using the IL-6 ELISA mentioned before.
The results from the experiment are presented in Fig. 4.9. For blackberry, blueberry and black
currant, all the dosages used, 10, 20 and 40 μM, significantly reduced the production of IL-6
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induced by 100 ng/ml LPS (P<0.05). For the anthocyanins extracted from cranberry, the lowest
effective concentration required was 20 μM.
Lipopolysaccharide has been demonstrated in previous studies by other researchers to
have the ability to induce acute inflammation in various cell models and animal studies (Kilroy
et al., 2007; Lu et al., 2008; Samokhvalov et al., 2009). Based on the results obtained from this
study, it was decided that 20 µM of berry anthocyanins was to be used for the treatment of
human preadipocytes in the following experiments described in Chapters 4.7, 4.8 and 4.9.
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Fig. 4.8 Effects of anthocyanins on IL-6 secretion in human preadipocytes media. Cells were
pretreated with BAB (A1), BUB (A2), CRB (A3), and BC (A4) anthocyanins (0, 10, 20, and 40
µM) for 24 h, and followed by incubation with 100 μM PA for 24 h. BAB: blackberry; BUB:
blueberry; CRB: cranberry; BC: black currant. The IL-6 levels of the anthocynin treated samples
are expressed as percentage of preadipocytes treated with 100 μM PA alone. Values represent
mean ± S.D of three independent experiments. *: P < 0.05.
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Fig. 4.9 Effects of anthocyanins on IL-6 secretion in human preadipocytes media. Cells were
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µM) for 24h, and followed by incubation with 100 ng/ml LPS for 8 h. The IL-6 levels of the
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4.7 Effects of Berry Anthocyanins on NF-κB
To determine the effects of anthocyanins on NF-κB induced by PA- or LPS- in human
preadipocytes, Western blot assay was performed on the cell lysates of the control and treated
samples as described in Chapter 3.6. The results presented in Fig.4.10 A and B show the levels
of NF-κB in the cell lysates of the control and treated cells. In the prevention treatment, the
levels of NF-κB in the preadipocytes were pre-incubated with BAB, BUB, CRB, or BC extracts,
followed by 100μM PA treatment were 66.1 ± 24.2%, 72.1 ± 19.3%, 74.3 ± 14.5%, and 83.1 ±
3.0% of the control, respectively. The levels of NF-κB in preadipocytes pretreated with BAB,
BUB, CRB or BC extracts, followed by 100ng/ml LPS treatment were 83.4 ± 7.6%, 69.4 ±
28.3%, 69.6 ± 16.6%, and 64.3 ± 11.2% of the control, respectively. These results show that the
NF-κB levels in all the samples were significantly (P<0.05) decreased when human
preadipocytes were pretreated with anthocyanins. There was no significant difference (P>0.05)
between the PA- and LPS- induced inflammation.
In the intervention strategy, human preadipocytes were exposed to PA or LPS followed
by the addition of anthocyanins. The NF-κB levels in human preadipocytes induced by PA- and
followed by the incubation with BAB, BUB, CRB, or BC extracts were 85.3 ± 18.4%, 104.6 ±
19.7%, 102.1 ± 20.1%, and 76.2 ± 31.0% of the control, respectively. The levels of NF-κB in
human preadipocytes treated by LPS and followed by BAB, BUB, CRB or BC treatments were
88.9 ± 13.9%, 90.0 ± 6.3%, 82.4 ± 23.5%, and 87.0 ± 6.1% of the control, respectively. Inthis
strategy, BAB, BUB and CRB did not show the similar inhibitory effect as observed in the
prevention treatment. Only the treatment with BC anthocyanins significantly (P<0.05) decreased
the NF-κB level in the human preadipocytes.
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Fig. 4.10 Effects of anthocyanins on the production of NF-κB induced by PA (A) or LPS (B) in
human preadipocytes as preventative and intervention measures. In the prevention treatment,
human preadipocytes were pretreated with anthocyanins at 20 μM for 24h, followed by
incubation with 100 µM PA for 24h or incubation with 100 ng/ml LPS. In the intervention
treatment, human preadipocytes were treated with PA 100 µM or LPS 100 ng/ml, followed by
incubation with 20 µM anthocyanins for 24 h. NF-κB levels were determined by Western blot
and quantified by “Quantity one”. Results are representatives of three donors’ experiments. The
values of NF-κB are expressed as percentage of preadipocytes treated with 100 μM PA alone
or100 ng/ml LPS alone. The value represents the mean ± S.D. of triplicate determinations, * P <
0.05, ** P<0.001.
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The transcription nuclear factor-κB (NF-κB) plays an important role in controlling the
inflammation and metabolic alterations associated with obesity (Sonnenberg et al., 2004; Wellen
et al., 2005). It has been reported that anthocyanins or berry extracts attenuated the inflammation
by NF-κB cell signaling in different cell models including murine macrophage RAW 264 cells,
macrophages, adipocytes, preadipocytes, endothelioma cell line and also in animal models (Afaq
et al., 2005; Atalay et al., 2003; Karlsen et al., 2007; Wang et al., 2008; Zafra-Stone et al., 2007).
It is noteworthy that other phytochemicals such as procyanidins, lycopene, resveratrol
and curcumin have also been reported to display similar anti-inflammatory properties in various
models including macrophages, monocytes or adipocytes, via a modulation of the NF-κB
pathway (Chacón et al., 2009; Gonzales et al., 2008; Karlsen et al., 2007). In our study, NF-κB
signaling pathway was activated by PA or LPS. The western blot results confirmed that
anthocyanins cause down-regulation of NF-κB when human preadipocytes were pretreated with
anthocyanins. Black currant anthocyanins may be speculated to have potent pharmacological
ability because of its inhibitory effects on NF-κB in human preadipocytes.
4.8 Effects of Berry Anthocyanins on COX-2
To determine the effects of anthocyanins on COX-2 induced by PA or LPS in human
preadipocytes, Western blot assay was performed on the cell lysates of control and treated
samples described in Chapter 3.6. The results are presented in Fig.4.11 A and B. In the
prevention treatment, the levels of COX-2 in the preadipocytes pretreated with BAB, BUB,
CRB, or BC extracts, followed by PA-stimulation were 79.2 ± 20.8%, 81.2 ± 9.6%, 77.1 ±
17.6%, and 67.9 ± 13.1% of the control, respectively. The levels of COX-2 in the preadipocytes
pretreated with BAB, BUB, CRB, or BC extracts, followed by LPS-incubation were 71.7 ±
17.1%, 80.4 ± 17.2%, 81.1 ± 24.4%, and 86.7 ± 9.8% of the control, respectively. Statistical
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analysis of these results indicates that anthocyanins extracted from all four berry types
significantly (P<0.05) suppressed the expression of COX-2. There was no significant (P>0.05)
difference in the OCX-2 levels in the samples stimulated by PA and LPS.
In the intervention experiment, the COX-2 levels in human preadipocytes treated with
PA, followed by BAB, BUB, CRB, or BC extracts were 89.3 ± 10.9%, 110.8 ± 27.3%, 100 ±
34.4%, and 88.1 ± 10.3% of the control, respectively. The COX-2 levels in human preadipocytes
treated with LPS and followed by the incubation with BAB, BUB, CRB, or BC extracts were
91.6± 12.1%, 92.6 ± 4.9%, 96.2 ± 9.0%, and 92.2 ± 5.7% of control, respectively. In this
strategy, the levels of COX-2 induced by PA or LPS did not significantly decrease (P>0.05)
when the human preadipocytes were treated with BAB, BUB, and CRB anthocyanins. However,
BC anthocyanins significantly (P<0.05) decreased COX-2 expression in human preadipocytes.
No significant difference (P>0.05) was found between PA- and LPS- treatments. Again, there
was no significant difference (P>0.05) between the PA and LPS treatments.
COX-2 is another highly induced inflammatory mediators (Sellers et al., 2010). COX-2
enzyme activation was modulated by NF-κB cell signaling pathway (Chuang et al., 2011;
Gonzales et al., 2008; Hou et al., 2005). Anthocyanins or anthocyanin-rich berry extracts from
cranberry, grape, or blueberry were reported to be able to inhibit COX-2 expression in several
cell models including human adipocytes, murine macrophages, mouse epidermal cells, RAW
264.7 cell line, THP-1 macrophages, and BV2 cells (Chuang et al., 2011; Hou et al., 2005; Kwon
et al., 2007; Wang et al., 2008). Resveratrol and other phytochemicals also cited to have
inhibited COX-2 gene expression in adipocytes (Gonzales et al., 2008). In the present study, the
Western blot results confirmed the inhibitory effects of berry anthocyanins on COX-2 in human
preadipocytes.
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Fig. 4.11 Effects of anthocyanins on the production of COX-2 induced by PA (A) or LPS (B) in
human preadipocytes. In the prevention treatment, human preadipocytes were pretreated with
anthocyanins at 20 μM for 24h, followed by incubation with 100µM PA for 24h or incubation
with 100 ng/ml LPS. In the intervention treatment, human preadipocytes were treated with PA
100µM or LPS 100 ng/ml, followed by incubation with 20 µM anthocyanins for 24 h. Results are
representatives of three donors’ experiments. The values of COX-2 are expressed as percentage
of preadipocytes treated with 100 μM PA alone or100ng/ml LPS alone. The value represents the
mean ± S.D. of triplicate determinations, *: P < 0.05, **: P<0.001.
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Thereby, the results of this study showed that in the prevention treatment berry
anthocyanins from BAB, BUB, CRB and BC at a concentration of 20 µM significantly (P<0.05)
inhibited the expression of NF-κB and COX-2 either induced by PA or LPS in human
preadipocytes. The mechanisms of the inhibitory effects of anthocyanins on NF-κB activation
are not fully understood. One possible mechanism is that anthocyanins or other metabolites serve
as redox buffers capable of suppressing oxidative stress and thereby dampening the
inflammatory response by direct ROS scavenging (Karlsen et al., 2007).
4.9 Effects of Berry Anthocyanins on PA- or LPS- Activated Inflammatory Cytokines
4.9.1 Effects of Berry Anthocyanins on PA- or LPS- Induced IL-6
To further investigate the effects of anthocyanins on inflammatory cytokines, the IL-6
ELISA assay was performed in the supernatant of human preadipocytes media. The ELISA
results of IL-6 are shown in Fig.4.12 A and B. In the prevention treatment, the IL-6 levels in the
supernatant of human preadipocytes pretreated with BAB, BUB, CRB, or BC anthocyanins,
followed by incubation with PA were 64.4 ± 24.5%, 41.6 ± 40.0%, 62.6 ± 33.8%, and 55.1 ±
17.7% of the control, respectively. The IL-6 levels in human preadipocytes pretreated by BAB,
BUB, CRB, or BC anthocyanins, followed by LPS- treatment were attenuated to 65.2 ± 31.2% ,
57.9 ± 26.7%, 81.43 ± 18.6%, and 70.7 ± 16.1% of the control, respectively. Statistical analysis
of the data indicate that BAB, BUB, CRB or BC anthocyanins all significantly (P<0.05)
suppressed the IL-6 expression in human preadipocytes media. There was no significant
(P>0.05) difference between PA and LPS treatments.
In the intervention treatment, the IL-6 levels for the samples treated with BAB, BUB,
CRB, or BC anthocyanins were 116.1±22.4%, 96.8±23.5%, 80.3±21.2%, and 67.8±22.9% of the
control, respectively. In the parallel treatment with LPS, the IL-6 levels for the samples treated
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with BAB, BUB, CRB, or BC anthocyanins were 104.3±7.7%, 86.1±22.7%, 87.4±21.5%, and
84.7 ± 16.2% of the control, respectively. Statistically analysis of the results show that BAB,
BUB and CRB anthocyanins did not significantly (P>0.05) inhibit the IL-6 expression in human
preadipocytes media and there was no significant (P>0.05) difference between the PA and LPS
treatments. However, BC anthocyanins significantly (P<0.05) suppressed IL-6 expression either
induced by PA or LPS in this intervention strategy.
IL-6 is one of the pro-inflammatory cytokines and an important regulator of the acute
phase response. IL-6 is shown to be positively correlated with the degree of obesity as assessed
by body mass index (BMI) and type 2 diabetes patients (Tsuda, 2008; Vgontzas et al., 1997).
Anthocyanins or anthocyanins-rich berry extracts including grape, cranberry, or blueberry downregulate of IL-6 at protein or gene level in various cell models including adipocytes,
macrophages, and in vivo in mice plasma or adipose tissue (Bodet et al., 2006; Chuang et al.,
2011; DeFuria et al., 2009; Tsuda, 2008; Tsuda et al., 2006; Zhang et al., 2010). Other
phytochemicals such as lycopene, curcumin, resveratrol, or flavonols have also showed the
inhibitory effect on IL-6 in mice adipose tissue, adipocytes, or macrophages (Chacón et al.,
2009; Gonzales et al., 2008; Gouranton et al., 2010). In current study, anthocyanins extracted
from the four berries can efficiently suppress the IL-6 expression in human preadipocytes when
anthocyanins were used in the prevention treatment. The anthocyanins extracted from BC also
suppressed the IL-6 expression when used in the intervention treatment.
4.9.2 Effects of Berry Anthocyanins on PA- or LPS- Induced IL-8
The ELISA results of IL-8 are shown in Fig. 4.13 A and B. In the prevention trial with
PA, IL-8 levels were significantly (P<0.05) decreased to 43.6 ± 35.0%, 12.5 ± 12.8%, 15.9 ±
16.7% and 21.9 ± 18.4% of the control for the treatments with BAB, BUB, CRB, and BC
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Fig. 4.12 Effects of anthocyanins on IL-6 induced by PA (A) or LPS (B) in human preadipocytes.
In the prevention treatment, human preadipocytes were pretreated with anthocyanins at 20 μM for
24 h, followed by incubation with 100 µM PA for 24 h or incubation with 100 ng/ml LPS. In the
intervention treatment, human preadipocytes were treated with PA 100 µM for 24 h or LPS 100
ng/ml for 8h, followed by incubation with 20 µM anthocyanins for 24 h. The levels of IL-6 in the
supernatant of human preadipocytes were determined by ELISA. Results are representatives of
four donors’ experiments. The values of IL-6 are expressed as percentage of preadipocytes
treated with 100 μM PA alone or100 ng/ml LPS alone. The value represents the mean ± S.D. of
triplicate determinations, *: P < 0.05, **: P<0.001.
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Fig.4.13 Effects of anthocyanins on IL-8 induced by PA (A) or LPS (B) in human preadipocytes.
In the prevention treatment, human preadipocytes were pretreated with anthocyanins at 20 μM for
24 h, followed by incubation with 100 µM PA for 24 h or incubation with 100 ng/ml LPS. In the
intervention treatment, human preadipocytes were treated with PA 100 µM for 24 h or LPS 100
ng/ml for 8h, followed by incubation with 20 µM anthocyanins for 24 h. The levels of IL-8 in the
supernatant of human preadipocytes were determined by ELISA. Results are representatives of
four donors’ experiments. The values of IL-8 are expressed as percentage of preadipocytes
treated with 100 μM PA alone or100 ng/ml LPS alone. The insert represents the mean ± S.D. of
triplicate determinations, *: P < 0.05, **: P<0.001.
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anthocyanins, respectively. IL-8 levels were reduced to 59.8 ± 27.1%, 29.3 ± 10.2%, 67.4 ±
24.8% and 53.7 ± 30.2% of the controls with BAB, BUB, CRB, and BC anthocyanins,
respectively when LPS- was added to treat human preadipocytes. Statistical analysis of the
results demonstrates that BAB, BUB, CRB and BC anthocyanins all significantly (P<0.05)
attenuated IL-8 expression in human preadipocytes media when they were used at 20 μM to
pre-treated the human preadipocytes. There was no significant difference (P>0.05) between the
PA and LPS treatments.
In the intervention trial with PA, the IL-8 results for the treatments with BAB, BUB,
CRB, or BC were 68.8 ±23.8%, 84.3±36.9%, 73.3 ± 48.7%, and 72.1±19.3% of the control,
respectively. In the parallel intervention trial with LPS, the IL-8 results of BAB, BUB, CRB, or
BC was decreased to 94.1±15.6%, 85.4±18.2%, 89.6 ± 22.1%, and 71.6 ± 18.1% of the control,
respectively. BAB, BUB and CRB anthocyanins did not significantly (P>0.05) inhibit the IL-8
expression in human preadipocytes media and this is true for both trials with PA and LPS.
However, BC anthocyanins significantly (P<0.05) suppressed IL-8 expression either induced by
PA or LPS.
Previous studies have shown that anthocyanins or anthocyanins-rich berry extracts from
various berries such as blueberry, cranberry, or grape, attenuated IL-8 expression in adipocytes,
macrophages, or endothelial cells. Anthocyanins also showed inhibitory effects on IL-8 levels in
human or experimental mice (Beltran-Debon et al., 2010; Bodet et al., 2006; Chuang et al., 2011;
Youdim et al., 2002; Zafra-Stone et al., 2007). Fig. 4.13 A and B show that anthocyanins
extracted from the four berries significantly (P<0.05) attenuated pro-inflammatory cytokine, IL8, expression in supernatant of human preadipocytes media in the prevention treatment, but not
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in the intervention treatment. The anthocyanins extracted from BC also suppressed the
expression in the intervention treatment.
4.9.3 Effects of Berry Anthocyanins on PA- or LPS- Induced MCP-1
The ELISA results of MCP-1 levels are shown in Fig. 4.14 A and B. In the prevention
treatments, MCP-1 levels of BAB, BUB, CRB or BC anthocyanins treated samples were 63.2 ±
20.3%, 49.3 ± 36.6%, 43.1 ± 35.5%, and 48.9± 41.7% of the PA- control, respectively. The
MCP-1 levels for the BAB, BUB, CRB, and BC anthocyanins treated samples were 90.7 ±
16.8%, 69.2 ± 35.7%, 62.2 ± 32.9%, and 74.5± 23.1% of the LPS control, respectively. Further
statistical analysis of the results show that BAB, BUB, CRB and BC anthocyanins significantly
(P<0.05) decreased MCP-1 expression in the human preadipocytes treated by PA. For the
samples induced with LPS, BUB, CRB, and BC significantly (P<0.05) decreased MCP-1 levels
in the samples but BAB did not significantly (P>0.05) suppress the expression of MCP-1 in the
cells.
In the intervention treatment, the MCP-1 levels for the samples treated with BAB, BUB,
CRB, or BC were 76.6 ± 24.0%, 99.3 ± 50.9%, 59.9 ± 40.0%, and 45.1 ± 35.2% of the PA
control, respectively. The MCP-1 levels in LPS-induced samples were 85.9±18.9%, 79.6
±10.6%, 74.3 ± 14.0%, and 72.6 ± 22.9% of the control, respectively. Statistical analysis of the
data show that the MCP-1 expression in BAB, BUB, or CRB anthocyanins treated human
preadipocytes conditioned media was not significantly different (P>0.05) from the control in
both cases with PA- and LPS- induced samples. However, BC anthocyanins significantly
(P<0.05) decreased the MCP-1 expression in both PA- and LPS- induced samples.
Obese individuals have higher circulating concentrations of MCP-1 compared to their
lean counterparts (Van Gaal et al., 2006). Pro-inflammatory adipokine, MCP-1, is expressed in
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the adipose tissue and induces macrophage infiltration which largely participates in the lowgrade inflammation of adipose tissue (Fasshauer et al., 2004; Gerhardt et al., 2001; Malavazos et
al., 2005). In vitro data showed that anthocyanins or anthocyanins-rich products such as
blueberry, cranberry, grape, or red wine inhibited MCP-1 expression in different cell models
including endothelium cells, human adipocytes and macrophage (Atalay et al., 2003; Chuang et
al., 2011; Garcia-Alonso et al., 2009; Youdim et al., 2002; Zafra-Stone et al., 2007). In vivo
study also showed that MCP-1 circulating levels in human plasma were decreased by red wine
anthocyanins or anthocyanins-rich Hibiscus sabdariffa (Beltran-Debon et al., 2010; GarciaAlonso et al., 2009). The results from the present study confirmed that anthocyanins downregulated MCP-1 secretion induced either by PA or LPS in primary culture of human
preadipocytes. The attenuation of MCP-1 expression in human preadipocytes may decrease
macrophage infiltration.
The antioxidant effects of anthocyanins have been observed in vivo experimental models
of healthy animals exposed to severe oxidative stress. In vitro experiments also illustrated the
anti-inflammatory capacity of anthocyanins may be due to their antioxidant property for
protecting cells from oxidative damage (Jensen et al., 2008; Tarozzi et al., 2005; Tsuda et al.,
1999). Elevated levels of pro-inflammatory cytokines in adipose tissue are causative factors for
the cardiovascular disease, diabetes, hypertension, obesity, insulin resistance, and other chronic
diseases (Atalay et al., 2003; Cimino et al., 2006; Herath et al., 2003; Hou et al., 2005; Karlsen et
al., 2007; Trayhurn, 2005). Dietary strategies for alleviating the metabolic complications of
obesity are being pursued as alternatives to pharmaceutical interventions (Cefalu et al., 2008).
NF-κB is a transcription factor that is important for the activation of many inflammatory
mediators, cytokines (e.g., IL-6, IL-8, and IL-1β), and the COX-2 enzyme (Dendorfer et al.,
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1994; Galien et al., 1996; Slogoff et al.). Anthocyanins can attenuate NF-κB actions and limit the
inflammatory response (e.g. IL-6, IL-8, MCP-1 and COX-2). Thereby, their application can be a
potential strategy to prevent the prevalence of obesity-associated pathologies.
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Fig.4.14 Effects of anthocyanins on MCP-1 induced by PA (A) or LPS (B) in human
preadipocytes. In the prevention treatment, human preadipocytes were pretreated with
anthocyanins at 20 μM for 24 h, followed by incubation with 100 µM PA for 24 h or incubation
with 100 ng/ml LPS for 8 h. In the intervention treatment, human preadipocytes were treated with
PA 100 µM for 24 h or LPS 100ng/ml for 8h, followed by incubation with 20 µM anthocyanins
for 24 h. The levels of MCP-1 in the supernatant of human preadipocytes were determined by
ELISA. Results are representatives of four donors’ experiments. The values of MCP-1 are
expressed as percentage of preadipocytes treated with 100 μM PA alone or100 ng/ml LPS alone.
The insert represents the mean ± S.D. of triplicate determinations, *: P < 0.05, **: P<0.001.
The results from the present study indicate the inhibitory effects of anthocyanins on the
production of pro-inflammatory cytokines including IL-6, IL-8, MCP-1, NF-κB and COX-2. In
addition, the prevention treatment with berry anthocyanins inhibited PA- or LPS- induced proinflammatory cytokines expression in human preadipocytes. The intervention treatment with the
berry anthocyanins did not have significant reduction (P>0.05) on the expression of the
cytokines.
The berry anthocyanins attenuated the inflammatory effects of saturated fatty acids or
LPS stimulation. The results of the present study may suggest that consumption of berries may
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prevent obesity-associated inflammation and associated chronic diseases. The data from the
prevention treatment indicate better attenuation effects on pro-inflammatory cytokines
expression than from the intervention treatment. This suggests that berries may possess disease
preventing properties rather than therapeutic and pharmacologic properties. The attenuation of
inflammation in human preadipocytes especially MCP-1 may decrease the infiltration of
macrophages into adipose tissue. Previous studies by other researchers have illustrated that
attenuated inflammation in human preadipocytes may diminish the accumulation of triglyceride
in the process of differentiation of human preadipocytes into adipocytes (van Tienen et al., 2011;
Yi et al., 2011). Therefore, an increase in consumption of berries may be a good method for
weight loss.
Because of the association between inflammatory cytokines and insulin resistance in
adipose tissue, reduction of the pro-inflammatory cytokines secretion in human preadipocytes
may prevent insulin resistance in adipose tissue and attenuate the insulin resistance related
diseases.
4.10 Future Work
The present study tested the expression of some pro-inflammatory cytokine proteins in
human preadipocytes treated with berry anthocyanins in absence or presence of PA or LPS.
Future work should address mRNA expression. The results demonstrated that berry anthocyanins
modulated the pro-inflammatory cytokines expression by NF-κB signaling pathway; however,
the molecular mechanism of this process is not completely understood. In future studies human
preadipocytes will be differentiated into adipocytes. The effects of anthocyanins on proinflammatory cytokines in human adipocytes will also be studied. In addition, an in vivo test is
necessary to understand the mechanism by which anthocyanins modulate inflammation in
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preadipocytes. Mice will be fed with berries or berry products and the changes of several proinflammatory cytokines will be evaluated in blood and adipose tissue.
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CHAPTER 5
SUMMARY AND CONCLUSION
Inflammation plays an important role in the development of obesity. Free fatty acids
produced by adipocytes or ingested from diets can induce low-grade, chronic inflammation.
Anthocyanins, the natural pigments of berries, are novel, safe, and proven antioxidants and
chemopreventive agents. The results from the present study have illustrated the antiinflammatory ability of anthocyanins-enriched berry extracts including blackberry, blueberry,
cranberry, and black currant. In general, the prevention strategy by the application of berry
extracts significantly (P<0.05) decreased the PA- or LPS-induced pre-inflammatory cytokines.
However, most pre-inflammatory cytokines expressions in the intervention studies were not
significantly decreased (P>0.05) by berry extracts. From this study we might conclude that
dietary treated with anthocyanins alleviates the inflammation state induced by PA or LPS in
human preadipocytes. Thereby, berry rich diets might be a good strategy for preventing obesity
and alleviating chronic diseases. The reduction in pre-inflammatory cytokines expression in
human preadipocytes pre-treated with BAB, BUB. CRB and BC suggests that berry extracts may
inhibit one of the primary steps in this inflammatory pathway.
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